| Monday
12 March
2007 |
|
 |
|
| 08.00 |
Registration |
|
|
08.45
|
BALLROOM Chairman's Welcome Address Al Sokol, Partner, Edwards Angell Palmer & Dodge LLP |
|
|
09.00 |
Keynote
Presentation Dr Alvaro Pascual-Leone, Professor in Neurology, Harvard Medical School, Director, Center for Non-Invasive Brain Stimulation, Associate Director, Harvard-Thorndike General Clinical Research Center, Beth Israel Deaconess Medical Center |
09.15 |
Keynote Address Dennis Purcell, Senior Managing Director, Aisling Capital |
|
|
09.30 |
Panel: Capital Markets: Reverse mergers and PIPE’s Chair: Stan Yakatan, Chairman, Katan Associates Panellists: David Reese, PhD, Managing Director, Healthcare Group, Cornell Capital Partners Matt Gardella, Partner & Co-Chair, Securities & Public Companies Practice, Edwards Angell Palmer & Dodge Peter Kash, Two River Group Holdings |
|
|
10.15 |
Coffee
Break |
|
|
10.40
|
Small Cap Listed Company Presentations |
|
|
12.40 |
Lunch |
|
|
13.40 |
Panel Discussion: Funding Early Stage Innovation:
Problem or Opportunity? Chair: Maggie Flanagan LeFlore, Ph.D., Head, R&D Ventures, AstraZeneca Panellists: Jeremy Levin, Head of Strategic Alliances, Novartis Institutes for Biomedical Research Janice Bourque, Senior Vice President & Group Head Life Sciences, Comerica Bank Isaac Kohlberg, Senior Associate Provost & Chief Technology Development Officer, Harvard University |
|
|
14.30 |
Panel
Discussion: Investment Trends Chair: Michael Lytton, General Partner, Oxford Bioscience Partners Panellists: Jonathan Leff, Managing Director,Warburg Pincus Doug Cole, General Partner, Flagship Ventures Christopher K. Mirabelli, Ph.D., Healthcare Ventures Jesper Zeuthen, Managing Director, Biomedical Venture, BankInvest Group |
|
|
15.15 |
Coffee
Break |
|
|
15.35 |
Sector Workshops Venture Funded Early - Mid Stage Biotech Companies |
|
|
17.40 |
Panel
Discussion: Accelerating Drug Discovery Through Innovative Collaborations
Chair: Mark Chalek, Chief Business Ventures, Beth Israel Deaconess Medical Centre Panellists: John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals Mason “Skip” Irving, Managing Director, Health Advances LLC Deborah Brooks, President, Michael J. Fox Foundation for Parkinson’s Research |
|
|
18.20 |
Cocktail
Reception |
|
|